Search company, investor...

Predict your next investment

Angel Investor (Group)
bellevc.com

Investments

7

Portfolio Exits

2

About BELLE Capital

Belle Capital is an early stage angel fund focused on building companies in Michigan, the Midwest and other underserved geographic markets. Belle Capital looks for capital efficient companies with a unique product or service filling an urgent market need and targets the mobile/internet/IT, technology-enabled services, life sciences/medical devices, advanced manufacturing and CleanTech market sectors. Companies seeking Belle Capital's investments must have at least one female founder or C-level exec, and/or be willing to recruit top female talent to the C-suite and Board of Directors.

Headquarters Location

217 Lake Shore Road

Auburn Hills, Michigan, 48326,

United States

(415) 300-7079

Want to inform investors similar to BELLE Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest BELLE Capital News

Hello Alice Raises $21M Series B

Jun 15, 2021

Back to HomeHOUSTON, TX, Hello Alice announced a $21 million Series B raise led by QED Investors.Hello Alice, a machine learning platform connecting small business owners to capital, networks and business services, announced a $21 million Series B raise led by QED Investors with participation from new investors including Backstage Capital, Green Book Ventures, Harbert Growth Partners, and How Women Invest.The full list of Series B investors in as follows: Backstage Capital, Blue Ivy, Cathie Reid, BCO Venture Fund, Belle Capital, Jacki Zehner, Jake Hastings, Harbert Growth Partners, How Women Invest, Golden Seeds, Green Book Ventures, Jean Case, Lovell Family, QED Investors, Ring Fund, Shatter Fund, Signia Venture Partners, and Silicon Valley Bank. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

BELLE Capital Investments

7 Investments

BELLE Capital has made 7 investments. Their latest investment was in Ocuphire Pharma as part of their Series A on July 7, 2019.

CBI Logo

BELLE Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/22/2019

Series A

Ocuphire Pharma

$5M

Yes

10

5/10/2019

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

1/26/2018

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

12/22/2017

Series A

Subscribe to see more

$99M

Subscribe to see more

10

3/26/2015

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/22/2019

5/10/2019

1/26/2018

12/22/2017

3/26/2015

Round

Series A

Series A - II

Unattributed VC

Series A

Series A - II

Company

Ocuphire Pharma

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$5M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

10

10

10

10

BELLE Capital Portfolio Exits

2 Portfolio Exits

BELLE Capital has 2 portfolio exits. Their latest portfolio exit was Cardialen on December 14, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/14/2022

Acquired

$99M

2

6/18/2020

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/14/2022

6/18/2020

Exit

Acquired

Reverse Merger

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

2

10

BELLE Capital Team

1 Team Member

BELLE Capital has 1 team member, including current Managing Partner, Lauren Flanagan.

Name

Work History

Title

Status

Lauren Flanagan

Managing Partner

Current

Name

Lauren Flanagan

Work History

Title

Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.